Several studies have hypothesized that VEGF may stimulate angiogenesis in colon cancer, and this is strongly supported by results showing that bevacizumab-induced VEGF inhibition leads to decreased angiogenesis and the abrogation of cancer growth [22, 29]. Here, VEGFA is linked to malignant colon neoplasm.